Why is PT-141 not working?

The approved studies measured a modest average effect in one group of people. They do not promise it works for everyone. RECONNECT tested 1.75 milligrams, taken as needed, in 1,267 women with low sexual desire that causes distress, who had not reached menopause, over 24 weeks. Desire scores rose by 0.35 on a desire questionnaire (the FSFI desire scale) compared with a dummy shot. Nausea, flushing, and headache each showed up in 10% or more. The 52-week follow-on in 684 women, where everyone knew they were getting the drug, only tracked safety. So it cannot show that the effect still beats a dummy shot. Use in men is off-label. This site holds no study that explains why a given person would feel nothing.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of names, absences, and legal limits. Brand versus molecule, side effects this site's citations did not measure, how long the trials actually ran, what national legal-status fields can say, and why two-compound answers do not scale to a larger stack.